BMC’s Yawkey building doors are now closed as an entrance as part of our ongoing efforts to enhance our campus and provide you with the best clinical care.

All patients and visitors on our main campus must enter our hospital via Shapiro, Menino, or Moakley buildings, where they will be greeted by team members at a new centralized check-in desk before continuing to the hospital. We are excited to welcome you and appreciate your patience as we improve our facilities.


Geoffrey R Oxnard, MD, is a thoracic oncologist at Boston Medical Center (BMC), internationally recognized for both his clinical expertise in lung cancer and for his pioneering work on the use of liquid biopsies to guide the selection of targeted therapies. Dr. Oxnard sees patients one day a week at BMC, while also fulfilling his roles as researcher, associate professor of Hematology and Medical Oncology at Boston University Chobanian & Avedisian School of Medicine, and vice president and global medical lead for liquid biopsies at Foundation Medicine. Dr. Oxnard’s clinical and research interests focus on the use of diagnostics to enable precision lung cancer therapies, as well as understanding inherited lung cancer risk. After receiving his medical degree from the University of Chicago-Pritzker School of Medicine, Dr. Oxnard completed a residency in Internal Medicine at Massachusetts General Hospital and a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center.

  • Administrative Title

    Associate Professor of Hematology and Medical Oncology, Boston University Chobanian and Avedisian School of Medicine

  • Residency

    Internal Medicine, Massachusetts General Hospital Residency, 2005-2008
  • Fellowship

    Hematology and Medical Oncology, Memorial Sloan Kettering Cancer Center, 2008-2011
  • Board Certifications

    Medical Oncology, American Board of Internal Medicine